ClinConnect ClinConnect Logo
Search / Trial NCT02130895

Testing CDS in OSCAR EMR Using STOPP Criteria

Launched by UNIVERSITY OF BRITISH COLUMBIA · May 5, 2014

Trial Information

Current as of August 02, 2025

Completed

Keywords

Prescribing Stopp Criteria Potentially Inappropriate Prescribing Clinical Decision Support Electronic Medical Records Primary Care

ClinConnect Summary

The STOPP (Screening Tool of Older People's potentially inappropriate Prescriptions) criteria are a previously clinically validated set of suggested medications to avoid in patients aged 65+ with certain characteristics (e.g. benzodiazepines should be avoided in those with a fall history). These have previously been translated into point of care reminders that can be used with the OSCAR Electronic Medical Record (EMR) so that physicians are notified of potentially inappropriate prescriptions when a patient's chart is opened. This two phase explanatory study will examine if those STOPP based...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Have been using the OSCAR EMR v 12.x for \>12 months (to provide enough time for medications to be consistently documented in the EMR).
  • Have OSCAR EMR installed locally in the practice.
  • Agree to be or are already a part of the University of British Columbia's Department of Family Practice's (UBC DFP) research network.
  • Ensure their OSCAR Service Provider (OSP) agrees to support the research network hardware/software installation.
  • Have not used the STOPP criteria in OSCAR prior to the study.
  • Exclusion Criteria:
  • Non-prescribers.
  • Those who do not provide longitudinal care (e.g. walk-in clinics).
  • Specialists or midwives.
  • Those who do not have regular patients over age 64 (e.g. maternity clinics).
  • Those who do not use OSCAR 12.1 or those that do not document prescriptions in their EMR prescription module.
  • Those who have ALREADY used the STOPP rules in OSCAR prior to the study.

About University Of British Columbia

The University of British Columbia (UBC) is a leading research institution located in Vancouver, Canada, renowned for its commitment to advancing health sciences through innovative research and education. As a prominent clinical trial sponsor, UBC leverages its interdisciplinary expertise and state-of-the-art facilities to conduct rigorous clinical studies aimed at improving patient outcomes across various medical fields. The university fosters collaborations with healthcare professionals, industry partners, and community stakeholders to translate research findings into practical applications, thereby contributing to the global advancement of medicine and public health.

Locations

Multiple Expected, British Columbia, Canada

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials